HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Paul A Baldock Selected Research

Bone Diseases (Bone Disease)

7/2013Matrix metalloproteinase-driven endochondral fracture union proceeds independently of osteoclast activity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Paul A Baldock Research Topics

Disease

14Obesity
02/2021 - 04/2002
10Body Weight (Weight, Body)
01/2019 - 02/2008
5Weight Gain
02/2021 - 10/2005
3Insulin Resistance
02/2021 - 01/2018
3Bone Resorption
01/2017 - 10/2006
2Glucose Intolerance
01/2018 - 11/2011
2Multiple Myeloma
01/2017 - 12/2015
2Atrophy
11/2015 - 07/2015
2Vitamin D Deficiency
11/2015 - 07/2015
2AIDS-Related Complex (ARC)
02/2013 - 12/2012
2Osteoporosis
12/2012 - 07/2010
1Overnutrition
02/2021
1Thinness
02/2021
1Muscular Atrophy (Muscle Atrophy)
10/2019
1Fatty Liver
10/2019
1Type 2 Diabetes Mellitus (MODY)
10/2019
1Sarcopenia
01/2018
1Hyperglycemia
01/2018
1Hyperinsulinism (Hyperinsulinemia)
01/2018
1Morbid Obesity
01/2018
1Musculoskeletal Diseases (Musculoskeletal Disease)
11/2015
1MASS syndrome
03/2015
1Bone Diseases (Bone Disease)
07/2013
1Hypogonadism (Hypergonadotropic Hypogonadism)
02/2009
1Hypertrophy
09/2008
1Wasting Syndrome (Wasting Disease)
11/2007
1Anorexia
11/2007
1Weight Loss (Weight Reduction)
11/2007
1Neoplasms (Cancer)
11/2007
1Osteonecrosis (Kienbock's Disease)
11/2003

Drug/Important Bio-Agent (IBA)

9LeptinIBA
12/2018 - 04/2002
8Glucose (Dextrose)FDA LinkGeneric
02/2021 - 02/2008
6Neuropeptide YIBA
01/2019 - 02/2008
3LipidsIBA
02/2021 - 02/2008
3Insulin (Novolin)FDA Link
02/2021 - 03/2015
3Vitamin DFDA LinkGeneric
11/2015 - 10/2006
3Calcitriol Receptors (Calcitriol Receptor)IBA
11/2015 - 10/2006
2Mechanistic Target of Rapamycin Complex 1IBA
02/2021 - 01/2018
2Therapeutic UsesIBA
10/2019 - 02/2008
2CytokinesIBA
10/2019 - 11/2007
2Hormones (Hormone)IBA
12/2018 - 02/2008
2Triglycerides (Triacylglycerol)IBA
01/2018 - 02/2008
2Dynorphins (Dynorphin)IBA
06/2014 - 12/2012
2Peptide YYIBA
01/2014 - 02/2008
2CorticosteroneIBA
07/2012 - 09/2008
1Biological ProductsIBA
10/2019
1Ciliary Neurotrophic Factor (CNTF)IBA
10/2019
1Interleukin-6 (Interleukin 6)IBA
10/2019
1Anabolic AgentsIBA
12/2018
1SecretagoguesIBA
01/2018
1Blood Glucose (Blood Sugar)IBA
01/2018
1Testosterone (Sustanon)FDA Link
01/2018
1OsteocalcinIBA
01/2018
1Diphosphonates (Bisphosphonates)IBA
01/2017
1Proteins (Proteins, Gene)FDA Link
01/2017
1Adrenergic Agents (Adrenergic Drugs)IBA
08/2014
1Opioid Analgesics (Opioids)IBA
06/2014
1AdipokinesIBA
01/2014
1Peptides (Polypeptides)IBA
01/2014
1GhrelinIBA
01/2014
1Glucagon-Like Peptides (Enteroglucagon)IBA
01/2014
1AdiponectinIBA
01/2014
1Glucagon-Like Peptide 2IBA
01/2014
1Bone Density Conservation AgentsIBA
07/2013
1Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)IBA
02/2013
1Uncoupling Protein 1IBA
02/2013
1Opiate AlkaloidsIBA
12/2012
1Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
12/2012
1Messenger RNA (mRNA)IBA
12/2012
1BIBO 3304IBA
07/2012
1LigandsIBA
06/2012
1Isoproterenol (Isoprenaline)FDA LinkGeneric
06/2012
1Adrenergic Agonists (Adrenergic Receptor Agonist)IBA
06/2012
1Pharmaceutical PreparationsIBA
11/2011
1Peroxisome Proliferator-Activated Receptors (PPAR)IBA
12/2010
1Muscle Proteins (Muscle Protein)IBA
12/2010
1SteroidsIBA
07/2010
1AndrogensIBA
02/2009
1Thyroxine (Levothyroxine)FDA LinkGeneric
09/2008
1Pro-Opiomelanocortin (Proopiomelanocortin)IBA
02/2008
1NeuropeptidesIBA
02/2008
1Thyrotropin-Releasing Hormone (Protirelin)FDA Link
02/2008
1Transforming Growth Factor beta (TGF-beta)IBA
11/2007
1Zoledronic Acid (Zometa)FDA Link
11/2003

Therapy/Procedure

2Therapeutics
12/2015 - 06/2014
1Bariatric Surgery
01/2012
1Castration
02/2009